CD277/BTN3A1 Antibody (BT3.1) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-00227PE
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunoprecipitation
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # BT3.1
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The immunogen for this antibody is CD277 (B7 family, Butyrophilin).
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Scientific Data Images for CD277/BTN3A1 Antibody (BT3.1) [PE]
Product Image: CD277/BTN3A1 Antibody (BT3.1) [PE] [NBP2-00227PE] - Vial of PE conjugated antibody. PE has two excitation maxima, 498 nm excited by the Blue laser (488 nm) and 565 nm excited by the Yellow-Green laser (561 nm). Both result in emission at 578 nm.
Applications for CD277/BTN3A1 Antibody (BT3.1) [PE]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD277/BTN3A1
Alternate Names
BT3.1, BTF5, BTN3A1, CD277
Gene Symbol
BTN3A1
Additional CD277/BTN3A1 Products
Product Documents for CD277/BTN3A1 Antibody (BT3.1) [PE]
Product Specific Notices for CD277/BTN3A1 Antibody (BT3.1) [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...